Cargando…

Maternal depression, antidepressant prescriptions, and congenital anomaly risk in offspring: a population-based cohort study

OBJECTIVE: To estimate risks of major congenital anomaly (MCA) among children of mothers prescribed antidepressants during early pregnancy or diagnosed with depression but without antidepressant prescriptions. DESIGN: Population-based cohort study. SETTING: Linked UK maternal–child primary care reco...

Descripción completa

Detalles Bibliográficos
Autores principales: Ban, L, Gibson, JE, West, J, Fiaschi, L, Sokal, R, Smeeth, L, Doyle, P, Hubbard, RB, Tata, LJ
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BlackWell Publishing Ltd 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4232879/
https://www.ncbi.nlm.nih.gov/pubmed/24612301
http://dx.doi.org/10.1111/1471-0528.12682
_version_ 1782344657661853696
author Ban, L
Gibson, JE
West, J
Fiaschi, L
Sokal, R
Smeeth, L
Doyle, P
Hubbard, RB
Tata, LJ
author_facet Ban, L
Gibson, JE
West, J
Fiaschi, L
Sokal, R
Smeeth, L
Doyle, P
Hubbard, RB
Tata, LJ
author_sort Ban, L
collection PubMed
description OBJECTIVE: To estimate risks of major congenital anomaly (MCA) among children of mothers prescribed antidepressants during early pregnancy or diagnosed with depression but without antidepressant prescriptions. DESIGN: Population-based cohort study. SETTING: Linked UK maternal–child primary care records. POPULATION: A total of 349 127 singletons liveborn between 1990 and 2009. METHODS: Odds ratios adjusted for maternal sociodemographics and comorbidities (aORs) were calculated for MCAs, comparing women with first-trimester selective serotonin reuptake inhibitors (SSRIs) or tricyclic antidepressants (TCAs) and women with diagnosed but unmedicated depression, or women without diagnosed depression. MAIN OUTCOME MEASURES: Fourteen system-specific MCA groups classified according to the European Surveillance of Congenital Anomalies and five specific heart anomaly groups. RESULTS: Absolute risks of MCA were 2.7% (95% confidence interval, 95% CI, 2.6–2.8%) in children of mothers without diagnosed depression, 2.8% (95% CI 2.5–3.2%) in children of mothers with unmedicated depression, and 2.7% (95% CI 2.2–3.2%) and 3.1% (95% CI 2.2–4.1%) in children of mothers with SSRIs or TCAs, respectively. Compared with women without depression, MCA overall was not associated with unmedicated depression (aOR 1.07, 95% CI 0.96–1.18), SSRIs (aOR 1.01, 95% CI 0.88–1.17), or TCAs (aOR 1.09, 95% CI 0.87–1.38). Paroxetine was associated with increased heart anomalies (absolute risk 1.4% in the exposed group compared with 0.8% in women without depression; aOR 1.78, 95% CI 1.09–2.88), which decreased marginally when compared with women with diagnosed but unmedicated depression (aOR 1.67, 95% CI 1.00–2.80). CONCLUSIONS: Overall MCA risk did not increase with maternal depression or with antidepressant prescriptions. Paroxetine was associated with increases of heart anomalies, although this could represent a chance finding from a large number of comparisons undertaken.
format Online
Article
Text
id pubmed-4232879
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BlackWell Publishing Ltd
record_format MEDLINE/PubMed
spelling pubmed-42328792014-12-15 Maternal depression, antidepressant prescriptions, and congenital anomaly risk in offspring: a population-based cohort study Ban, L Gibson, JE West, J Fiaschi, L Sokal, R Smeeth, L Doyle, P Hubbard, RB Tata, LJ BJOG Epidemiology OBJECTIVE: To estimate risks of major congenital anomaly (MCA) among children of mothers prescribed antidepressants during early pregnancy or diagnosed with depression but without antidepressant prescriptions. DESIGN: Population-based cohort study. SETTING: Linked UK maternal–child primary care records. POPULATION: A total of 349 127 singletons liveborn between 1990 and 2009. METHODS: Odds ratios adjusted for maternal sociodemographics and comorbidities (aORs) were calculated for MCAs, comparing women with first-trimester selective serotonin reuptake inhibitors (SSRIs) or tricyclic antidepressants (TCAs) and women with diagnosed but unmedicated depression, or women without diagnosed depression. MAIN OUTCOME MEASURES: Fourteen system-specific MCA groups classified according to the European Surveillance of Congenital Anomalies and five specific heart anomaly groups. RESULTS: Absolute risks of MCA were 2.7% (95% confidence interval, 95% CI, 2.6–2.8%) in children of mothers without diagnosed depression, 2.8% (95% CI 2.5–3.2%) in children of mothers with unmedicated depression, and 2.7% (95% CI 2.2–3.2%) and 3.1% (95% CI 2.2–4.1%) in children of mothers with SSRIs or TCAs, respectively. Compared with women without depression, MCA overall was not associated with unmedicated depression (aOR 1.07, 95% CI 0.96–1.18), SSRIs (aOR 1.01, 95% CI 0.88–1.17), or TCAs (aOR 1.09, 95% CI 0.87–1.38). Paroxetine was associated with increased heart anomalies (absolute risk 1.4% in the exposed group compared with 0.8% in women without depression; aOR 1.78, 95% CI 1.09–2.88), which decreased marginally when compared with women with diagnosed but unmedicated depression (aOR 1.67, 95% CI 1.00–2.80). CONCLUSIONS: Overall MCA risk did not increase with maternal depression or with antidepressant prescriptions. Paroxetine was associated with increases of heart anomalies, although this could represent a chance finding from a large number of comparisons undertaken. BlackWell Publishing Ltd 2014-11 2014-03-11 /pmc/articles/PMC4232879/ /pubmed/24612301 http://dx.doi.org/10.1111/1471-0528.12682 Text en © 2014 The Authors. BJOG An International Journal of Obstetrics and Gynaecology published by John Wiley & Sons Ltd on behalf of Royal College of Obstetricians and Gynaecologists. http://creativecommons.org/licenses/by/3.0/ This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Epidemiology
Ban, L
Gibson, JE
West, J
Fiaschi, L
Sokal, R
Smeeth, L
Doyle, P
Hubbard, RB
Tata, LJ
Maternal depression, antidepressant prescriptions, and congenital anomaly risk in offspring: a population-based cohort study
title Maternal depression, antidepressant prescriptions, and congenital anomaly risk in offspring: a population-based cohort study
title_full Maternal depression, antidepressant prescriptions, and congenital anomaly risk in offspring: a population-based cohort study
title_fullStr Maternal depression, antidepressant prescriptions, and congenital anomaly risk in offspring: a population-based cohort study
title_full_unstemmed Maternal depression, antidepressant prescriptions, and congenital anomaly risk in offspring: a population-based cohort study
title_short Maternal depression, antidepressant prescriptions, and congenital anomaly risk in offspring: a population-based cohort study
title_sort maternal depression, antidepressant prescriptions, and congenital anomaly risk in offspring: a population-based cohort study
topic Epidemiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4232879/
https://www.ncbi.nlm.nih.gov/pubmed/24612301
http://dx.doi.org/10.1111/1471-0528.12682
work_keys_str_mv AT banl maternaldepressionantidepressantprescriptionsandcongenitalanomalyriskinoffspringapopulationbasedcohortstudy
AT gibsonje maternaldepressionantidepressantprescriptionsandcongenitalanomalyriskinoffspringapopulationbasedcohortstudy
AT westj maternaldepressionantidepressantprescriptionsandcongenitalanomalyriskinoffspringapopulationbasedcohortstudy
AT fiaschil maternaldepressionantidepressantprescriptionsandcongenitalanomalyriskinoffspringapopulationbasedcohortstudy
AT sokalr maternaldepressionantidepressantprescriptionsandcongenitalanomalyriskinoffspringapopulationbasedcohortstudy
AT smeethl maternaldepressionantidepressantprescriptionsandcongenitalanomalyriskinoffspringapopulationbasedcohortstudy
AT doylep maternaldepressionantidepressantprescriptionsandcongenitalanomalyriskinoffspringapopulationbasedcohortstudy
AT hubbardrb maternaldepressionantidepressantprescriptionsandcongenitalanomalyriskinoffspringapopulationbasedcohortstudy
AT tatalj maternaldepressionantidepressantprescriptionsandcongenitalanomalyriskinoffspringapopulationbasedcohortstudy